The US Food and Drug Administration approves first of its kind medication for migraine prevention.
Matt Hoffman
Advertisement
Articles by Matt Hoffman
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Psychiatric Times
1
Lithium-Loaded Gold Nanoparticle Nasal Spray to Treat Neuropsychiatric Diseases
2
Preliminary Report on Dangers of AI Chatbots
3
The Trial of ChatGPT: What Psychiatrists Need to Know About AI, Suicide, and the Law
4
Suicide: Can Emergency Departments Assist in its Prevention?
5
